Quantitative selection and parallel characterization of aptamers

Aptamers are promising affinity reagents that are potentially well suited for high-throughput discovery, as they are chemically synthesized and discovered via completely in vitro selection processes. Recent advancements in selection, sequencing, and the use of modified bases have improved aptamer qu...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 110; no. 46; pp. 18460 - 18465
Main Authors: Cho, Minseon, Oh, Seung Soo, Nie, Jeff, Stewart, Ron, Eisenstein, Michael, Chambers, James, Marth, Jamey D., Walker, Faye, Thomson, James A., Soh, H. Tom
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 12-11-2013
NATIONAL ACADEMY OF SCIENCES
National Acad Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aptamers are promising affinity reagents that are potentially well suited for high-throughput discovery, as they are chemically synthesized and discovered via completely in vitro selection processes. Recent advancements in selection, sequencing, and the use of modified bases have improved aptamer quality, but the overall process of aptamer generation remains laborious and low-throughput. This is because binding characterization remains a critical bottleneck, wherein the affinity and specificity of each candidate aptamer are measured individually in a serial manner. To accelerate aptamer discovery, we devised the Quantitative Parallel Aptamer Selection System (QPASS), which integrates microfluidic selection and next-generation sequencing with in situ-synthesized aptamer arrays, enabling simultaneous measurement of affinity and specificity for thousands of candidate aptamers in parallel. After using QPASS to select aptamers for the human cancer biomarker angiopoietin-2 (Ang2), we in situ synthesized arrays of the selected sequences and obtained equilibrium dissociation constants (K d) for every aptamer in parallel. We thereby identified over a dozen high-affinity Ang2 aptamers, with K d as low as 20.5 ± 7.3 nM. The same arrays enabled us to quantify binding specificity for these aptamers in parallel by comparing relative binding of differentially labeled target and nontarget proteins, and by measuring their binding affinity directly in complex samples such as undiluted serum. Finally, we show that QPASS offers a compelling avenue for exploring structure−function relationships for large numbers of aptamers in parallel by coupling array-based affinity measurements with next-generation sequencing data to identify nucleotides and motifs within the aptamer that critically affect Ang2 binding.
Bibliography:http://dx.doi.org/10.1073/pnas.1315866110
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Contributed by James A. Thomson, August 23, 2013 (sent for review February 8, 2013)
1M.C. and S.S.O. contributed equally to this work.
Author contributions: M.C., S.S.O., and H.T.S. designed research; M.C., S.S.O., and J.C. performed research; M.C., S.S.O., J.N., R.S., J.C., J.D.M., and J.A.T. contributed new reagents/analytic tools; M.C., S.S.O., J.N., R.S., J.C., J.D.M., J.A.T., and H.T.S. analyzed data; and M.C., S.S.O., M.E., F.W., and H.T.S. wrote the paper.
2Present address: Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1315866110